SCHEMBL893105

SCHEMBL893105

CCCCCCNC(O)[C@H]1OC(OCC(COC2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)COC2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.54

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CETP P11597 1/20 0.51
SELP P16109 6/20 0.43
SELL P14151 5/20 0.43
SELE P16581 3/20 0.43
APP P05067 1/20 0.41
MAPK1 P28482 1/20 0.41
VEGFA P15692 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8333761 0.79 SELL (0.59) CETPSELPSELLSELEAPP
SCHEMBL8334049 0.79 SELL (0.59) CETPSELPSELLSELEAPP
SCHEMBL15618389 0.79 SELL (0.59) CETPSELPSELLSELEAPP
SCHEMBL1573005 0.79 SELL (0.59) CETPSELPSELLSELEAPP
SCHEMBL15618579 0.79 SELL (0.59) CETPSELPSELLSELEAPP
SCHEMBL8334043 0.79 SELL (0.59) CETPSELPSELLSELEAPP
SCHEMBL15618321 0.79 SELL (0.59) CETPSELPSELLSELEAPP
SCHEMBL8333751 0.79 SELL (0.59) CETPSELPSELLSELEAPP
SCHEMBL15618387 0.79 SELL (0.59) CETPSELPSELLSELEAPP
SCHEMBL15618578 0.79 SELL (0.59) CETPSELPSELLSELEAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120082728-A1 MULTIFUNCTIONAL STEALTH NANOPARTICULES FOR BIOMEDICAL USE UNIVERSITE DE STRASBOURG (FR) 2012-04-05 US claimed
US-20120082728-A1 MULTIFUNCTIONAL STEALTH NANOPARTICULES FOR BIOMEDICAL USE UNIVERSITE DE STRASBOURG (FR) 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120082728-A1 MULTIFUNCTIONAL STEALTH NANOPARTICULES FOR BIOMEDICAL USE EPHA2, CD47, MSN CETP 575/4885SELP 25/4885SELL 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.